Fronteo (TSE:2158) Dividend-Payout-to-FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2158 Fronteo Inc TSE:2158
45 GF Score
Price 円641.00
GF Value 円776.87
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Fronteo Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.

TSE:2158
45GF Score
Fronteo Inc TSE:2158
Dividend-Payout-to-FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fronteo (TSE:2158) Overvalued in 2026?

Based on GuruFocus' analysis, Fronteo stock appears to be undervalued. The current stock price of 円641.00 is trading 17.5% below its estimated GF Value™ of 円776.87. GuruFocus considers Fronteo to be Modestly Undervalued.

Key valuation signals for TSE:2158:

  • Dividend-Payout-to-FFO:
  • GF Value™: 円776.87 vs. price of 円641.00 (17.5% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the TSE:2158 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fronteo Business Description

Address 2-12-23 Kounan, 8th Floor, Meisan Takahama building, Minato-ku, Tokyo, JPN, 108-0075
Fronteo Inc. is a Japanese technology company specializing in artificial intelligence and data analytics solutions. It operates through three main segments. The Life Science AI business applies natural language processing to drug discovery and medical device development. The Risk Management business provides legal technology and business intelligence compliance services, supporting corporate litigation, investigations, and crisis management. The DX business helps companies integrate and digitize dispersed internal data to advance digital transformation. Fronteo primarily serves corporations, law firms, and healthcare organizations, with a focus on the Japanese market and expanding international operations. Its revenue comes from software licensing, subscription-based AI platforms, and professional services engagements. The company was formerly known as UBIC Inc. and changed its name to Fronteo in 2017.
45GF Score

Get the complete analysis for TSE:2158

Dividend-Payout-to-FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円641.00
Price
円776.87
GF Value